Dipankar Bhattacharjee

Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) announced that Dipankar Bhattacharjee, the CEO of Teva generics Europe, has been appointed as the new head of global generics. Deutsche Bank’s Gregg Gilbert maintains a Buy rating on the company, with a price target of $54. Executive...

Bernstein said the departure of Siggi Olafsson is negative for Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA), as investors may fear the move is reflective of deeper malaise. ADRs of Teva were down 3.89 percent in Tuesday’s pre-market hours. Olafsson's Departure Teva announced that...

After Monday's close, Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) announced Siggi Olafsson, head of global generics at the company, would be retiring at the end of Q1:17. BTIG’s Timothy Chiang maintains a Neutral rating on the company, while expressing surprise regarding the...